Engage with experts in gene therapy to learn about important considerations, the necessity of a strong plan for plasmid at the early stages of candidate development, and potential obstacles. Our panel will discuss the importance of continuity and consistency from early discovery through the different stages of drug development in preparation for commercialization. Learn about the original GMP-Source® service, developed in collaboration with leading gene therapy researchers, and how this continues to enable early phase clinical research.
- Importance of planning for plasmid in early stages of candidate development
- Best practices for ensuring material continuity and consistency from discovery through commercialization
- Evolution of GMP-Source® and phase-appropriate use of plasmid DNA